<DOC>
	<DOCNO>NCT02805972</DOCNO>
	<brief_summary>The purpose study understand opioid system involve eating behavior .</brief_summary>
	<brief_title>Biology Experience Eating</brief_title>
	<detailed_description>Obesity associate great risk cardiovascular disease ( CVD ) , stroke , diabetes , mortality , heterogeneous condition various cause thus diversity intervention target . Compulsive overeat afflict 30 % people seek obesity treatment increase risk CVD factor . This trial involve two participant visit test whether opioid blockade ( Day 1 2 , depend randomization ) , compare placebo ( Day 1 2 , depend randomization ) , elicit common symptom opioid withdrawal , include nausea . Participants receive condition separate day .</detailed_description>
	<mesh_term>Naloxone</mesh_term>
	<criteria>Obese , define BMI great equal 30 Selfreported binge eat define DSM5 , last 4 week If sexually active men , must agree use birth control final study visit complete ( e.g. , barrier method , oral contraceptive ) Subject must able complete write informed consent procedure able comply requirement study . Pregnant breastfeed Severe hypotension ( &lt; 90/60 mmHg ) Recent current use vasoconstrictor vasodilator medication Current history diabetes Allergies ingredient naloxone hydrochloride History current alcoholism drug dependence Bulimia Nervosa define DSM 5 Current past use opiatecontaining medication last 30 day Plan use opiatecontaining medication study participation period Medical condition contraindicate intranasal procedure : Nasal septal abnormality , nasal trauma , epistaxis , excessive nasal mucus , intranasal damage cause use substance ( e.g. , cocaine ) Presence condition abnormality opinion Investigator would compromise safety subject quality data</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Binge eating</keyword>
</DOC>